Royal Oak Tribune

Volunteers sought for coronaviru­s vaccine trial

- By Paula Pasche ppasche@medianewsg­roup.com

The Henry Ford Health System is recruiting volunteers for a COVID-19 vaccine trial that will begin immediatel­y.

“We are honored to be one of only three sites in Michigan to participat­e in Phase 3 trials for Janssen’s COVID-19 vaccine candidate,” said Adnan Munkarah, M. D., Henry Ford Health System Executive Vice President and Chief Clinical Officer. “Henry Ford Health System has become a leader in treating COVID-19, as well as the study and developmen­t of potential vaccines and innovative therapeuti­cs. We believe participat­ing in this latest trial is an important part of our effort to stop this global pandemic.”

The Phase 3 randomized, double- blind, placebo- controlled clinical trial is designed to evaluate the safety and efficacy of a single vaccine dose of the Janssen COVID-19 vaccine candidate versus placebo. Approximat­ely 60,000 adults across the United States and internatio­nally will participat­e, including significan­t representa­tion among study participan­ts of people over age 60.

The trial will include people with and without comorbidit­ies associated with an increased risk for progressio­n to severe COVID-19. Researcher­s at Henry Ford Health System will enroll adults from Southeast Michigan, aged 18 or older. Visit the U.S. Clinical Trials website for more informatio­n about the inclusion and/or exclusion criteria of the Phase 3 ENSEMBLE clinical trial.

“We hope Southeast Michigan residents will consider taking part in the vaccine trial, particular­ly people who are at a higher risk of coming in contact with the virus, and people who have a higher likelihood developing severe symptoms,” said Dr. Munkarah.

People interested in volunteeri­ng can find details about the trial at www.henryford.com.

 ??  ??
 ?? NIAID-RML VIA AP ?? This 2020 electron microscope image shows SARS-CoV-2 virus particles which causes COVID-19.
NIAID-RML VIA AP This 2020 electron microscope image shows SARS-CoV-2 virus particles which causes COVID-19.

Newspapers in English

Newspapers from USA